Steris PLC (NYSE:STE) VP Cary L. Majors Sells 5,250 Shares

Steris PLC (NYSE:STE) VP Cary L. Majors sold 5,250 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $152.67, for a total transaction of $801,517.50. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

STE opened at $153.94 on Friday. The firm has a 50 day moving average of $148.92. Steris PLC has a 1-year low of $99.14 and a 1-year high of $154.90. The company has a current ratio of 2.41, a quick ratio of 1.82 and a debt-to-equity ratio of 0.37. The firm has a market cap of $12.93 billion, a P/E ratio of 31.48 and a beta of 0.98.

Steris (NYSE:STE) last posted its quarterly earnings results on Monday, August 5th. The medical equipment provider reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.12. Steris had a net margin of 11.22% and a return on equity of 13.80%. The company had revenue of $696.80 million for the quarter, compared to the consensus estimate of $674.12 million. During the same period last year, the company posted $1.00 EPS. The firm’s quarterly revenue was up 9.1% compared to the same quarter last year. On average, equities analysts predict that Steris PLC will post 5.43 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Tuesday, September 10th will be paid a $0.37 dividend. This is an increase from Steris’s previous quarterly dividend of $0.34. This represents a $1.48 dividend on an annualized basis and a dividend yield of 0.96%. The ex-dividend date is Monday, September 9th. Steris’s dividend payout ratio (DPR) is presently 27.81%.

A number of equities research analysts have issued reports on STE shares. Stephens increased their price objective on shares of Steris from $135.00 to $150.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 15th. Zacks Investment Research upgraded shares of Steris from a “hold” rating to a “buy” rating and set a $146.00 price objective on the stock in a research note on Tuesday, April 30th. JMP Securities increased their price objective on shares of Steris from $135.00 to $150.00 and gave the stock a “market outperform” rating in a research note on Wednesday, May 22nd. Finally, KeyCorp increased their price objective on shares of Steris from $135.00 to $138.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 15th. Five research analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and an average price target of $148.20.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Comerica Securities Inc. increased its stake in Steris by 22.4% during the fourth quarter. Comerica Securities Inc. now owns 4,271 shares of the medical equipment provider’s stock worth $456,000 after acquiring an additional 782 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Steris by 8.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 652,757 shares of the medical equipment provider’s stock worth $69,740,000 after acquiring an additional 49,010 shares during the last quarter. Geode Capital Management LLC increased its stake in Steris by 7.1% during the fourth quarter. Geode Capital Management LLC now owns 827,744 shares of the medical equipment provider’s stock worth $88,444,000 after acquiring an additional 54,537 shares during the last quarter. State of Alaska Department of Revenue increased its stake in Steris by 1.6% during the first quarter. State of Alaska Department of Revenue now owns 9,031 shares of the medical equipment provider’s stock worth $1,156,000 after acquiring an additional 139 shares during the last quarter. Finally, First Citizens Bank & Trust Co. increased its stake in Steris by 38.7% during the first quarter. First Citizens Bank & Trust Co. now owns 4,771 shares of the medical equipment provider’s stock worth $611,000 after acquiring an additional 1,330 shares during the last quarter. Institutional investors own 84.09% of the company’s stock.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

See Also: What is the yield curve?

Insider Buying and Selling by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.